Inactive Instrument
Sector Plasmatech Biopharmaceuticals Inc Nasdaq
Stocks
US72754H1095
Pharmaceuticals
|
End-of-day quote
Other stock markets
|
||
| - USD | - |
|
| 08-04 | Abeona Therapeutics Inc. Grants New Technology Add-On Payment Status For ZEVASKYN | CI |
| 06-29 | Abeona Therapeutics Inc.(NasdaqCM:ABEO) dropped from Russell 3000E Growth Benchmark | CI |
Main competitors
| Change | 5-day change | 1-month change | 3-month change | YTD change | 1-year change | 3-year change | 5-year change | 10-year change | Capi.($) | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
| +1.59% | +6.23% | +20.71% | +8.78% | +1.62% | +41.29% | +2.34% | +28.40% | +85.43% | 77.1B | ||
| -0.84% | +2.81% | -12.30% | -5.47% | -6.50% | +22.05% | +180.42% | +137.49% | +221.10% | 49.43B | ||
| +2.77% | +1.90% | +10.75% | +5.14% | -8.20% | -1.84% | +27.14% | +10.12% | - | 49.27B | ||
| -0.13% | +3.33% | +6.41% | +6.10% | -23.43% | -50.97% | -50.14% | -55.63% | +15.26% | 44.59B | ||
| +0.80% | +0.00% | -0.25% | +9.05% | +18.15% | +60.77% | -22.68% | -38.84% | -34.19% | 30.48B | ||
| +1.84% | -1.98% | +4.27% | +20.74% | +22.06% | +55.26% | +89.47% | +58.01% | +32.72% | 24B | ||
| +9.86% | +2.16% | -27.67% | +21.27% | +100.64% | +121.53% | -45.31% | -85.70% | - | 21.5B | ||
| +4.29% | +7.66% | +4.81% | +4.69% | +24.39% | -3.26% | +189.18% | +27.66% | - | 20.18B | ||
| +1.66% | -4.10% | -5.58% | +2.77% | +36.18% | +68.10% | +124.13% | +173.26% | +315.02% | 16.29B | ||
| +2.03% | +2.85% | +8.66% | +24.07% | +10.45% | +88.53% | +170.34% | +56.16% | - | 16.19B | ||
| +3.92% | +41.86% | +19.79% | +9.08% | -11.79% | -9.78% | +761.96% | +422.86% | +6,265.22% | 14.37B | ||
| +3.82% | +5.33% | +8.54% | +16.87% | +7.37% | +5.18% | -27.93% | -18.33% | -35.51% | 11.88B | ||
| +1.24% | -9.33% | -12.31% | -4.44% | +16.48% | +106.02% | +188.81% | +315.83% | +2,666.45% | 10.81B | ||
| +1.17% | -11.01% | -12.87% | +12.96% | +32.41% | +140.04% | +162.84% | +444.99% | - | 9.55B | ||
| +0.69% | -2.02% | +12.26% | +12.13% | -4.91% | -20.57% | -21.85% | -50.92% | -47.61% | 6.95B | ||
| +6.04% | +26.65% | +15.75% | +94.31% | +264.66% | +346.60% | +403.35% | +4.42% | - | 6.84B | ||
| +2.18% | +2.64% | +3.88% | +17.80% | +2.38% | +8.28% | +64.52% | -3.68% | - | 6.01B | ||
| -0.59% | -2.74% | +21.17% | +30.62% | +84.39% | +132.46% | +315.63% | +479.28% | - | 5.97B | ||
| +9.98% | +19.22% | -18.38% | -6.83% | +14.28% | +31.81% | +255.50% | +245.22% | - | 5.67B | ||
| Average | +2.24% | +2.24% | +2.51% | +14.72% | +30.56% | +60.08% | +145.67% | +113.19% | +948.39% | 22.48B | |
| Weighted average by Cap. | +1.56% | +2.78% | +4.26% | +9.55% | +13.19% | +37.07% | +88.55% | +63.43% | +493.80% |
- Stock Market
- Stocks
- ABEO Stock
- Stock
- Sector Plasmatech Biopharmaceuticals Inc
Select your edition
All financial news and data tailored to specific country editions
















